explore -WSS

explore

author：Wikipedia 2025-09-29 19:57:36 - browse：83

Sarepta - Cambridge -AP — Kristoffer Tripplaar/Sipa via AP

To hear Sarepta CEO Doug Ingram tell it, the results Monday afternoon from a large trial of its gene therapy for Duchenne muscular dystrophy marked a clear medical breakthrough. “A massive win,” he told investors, that could lead to its approval for all patients with the fatal muscle-wasting disease regardless of age.

And yet the rest of the Duchenne community was more cautious in its enthusiasm. The study — the most rigorous test to date of a technology 30 years in the making — had technically failed, as so many had before it.

“It’s extremely frustrating,” said John Brandsema, a pediatric neurologist at Children’s Hospital of Philadelphia who worked on the study. “When you spend decades trying to bring therapies into the clinic for something so severe and just keep missing over and over again.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Poland's lawmakers approve a divisive law on Russian influence

WSS

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

Snowpack in the West is melting rapidly. Where will all that extra water go?

Many immigrants are left out of maternal health programs

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

Teacher posts viral 'school supply rant' with advice for parents

explore

explore

hotspot

At least 13 dead in Texas as scorching temps continue

Hospitals, health systems can help patients avoid medical debt

Continuity nursing helped my family in our darkest PICU moments

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

Sports medicine is finally prioritizing gender equality

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

What does generative AI mean for health care? We asked experts

Interest rates are at a 22

As demand for Covid shots wanes, Moderna seeks its next success

Stoke drug shows lower activity against childhood epilepsy

explore

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

Timeline: Special counsel's probe into Trump's handling of classified documents

HCA says smaller share of spending going to labor

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

'The boss' wants server deleted: New allegations emerge in Trump indictment

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

hotspot

focus

hotspot

knowledge